Cocrystal Pharma, Inc. (COCP) Financial Statements (2024 and earlier)

Company Profile

Business Address 19805 N. CREEK PARKWAY
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32,419,00033,981,00037,219,00042,056,00051,033,00054,789,000
Cash and cash equivalents32,419,00033,981,00037,219,00042,056,00051,033,00054,789,000
Restricted cash and investments75,00075,00075,00075,00075,00050,000
Receivables1,207,000956,000716,000   
Prepaid expense      
Other undisclosed current assets2,060,0002,224,0002,168,0002,765,000488,000560,000
Total current assets:35,761,00037,236,00040,178,00044,896,00051,596,00055,399,000
Noncurrent Assets
Operating lease, right-of-use asset167,000221,000274,000327,000378,000428,000
Property, plant and equipment305,000338,000342,000378,000363,000407,000
Intangible assets, net (including goodwill)      19,092,000
Goodwill      19,092,000
Deposits noncurrent assets46,00046,00046,00046,00046,00046,000
Total noncurrent assets:518,000605,000662,000751,000787,00019,973,000
TOTAL ASSETS:36,279,00037,841,00040,840,00045,647,00052,383,00075,372,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,421,0002,937,000976,0001,378,000971,0001,314,000
Accounts payable1,041,0002,654,000614,000897,000616,000858,000
Accrued liabilities380,000283,000362,000316,000211,000325,000
Other undisclosed accounts payable and accrued liabilities    165,000144,000131,000
Debt   7,00014,00021,00028,000
Derivative instruments and hedges, liabilities      1,000
Other undisclosed current liabilities166,000208,000233,000227,0001,821,000215,000
Total current liabilities:1,587,0003,145,0001,216,0001,619,0002,813,0001,558,000
Noncurrent Liabilities
Long-term debt and lease obligation:    119,000177,000234,000
Liabilities, other than long-term debt 10,00027,00057,000   
Operating lease, liability 10,00027,00057,000119,000177,000234,000
Other undisclosed noncurrent liabilities    (119,000)(177,000)(234,000)
Total noncurrent liabilities: 10,00027,00057,000119,000177,000234,000
Total liabilities:1,597,0003,172,0001,273,0001,738,0002,990,0001,792,000
Equity
Equity, attributable to parent34,682,00034,669,00039,567,00043,909,00049,393,00073,580,000
Common stock10,0008,0008,0008,00098,00098,000
Additional paid in capital341,957,000337,780,000337,489,000337,330,000337,024,000336,783,000
Accumulated deficit(307,285,000)(303,119,000)(297,930,000)(293,429,000)(287,729,000)(263,301,000)
Total equity:34,682,00034,669,00039,567,00043,909,00049,393,00073,580,000
TOTAL LIABILITIES AND EQUITY:36,279,00037,841,00040,840,00045,647,00052,383,00075,372,000

Income Statement (P&L) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Operating expenses(4,339,000)(5,111,000)(4,502,000)(5,694,000)(24,428,000)(4,205,000)
Operating loss:(4,339,000)(5,111,000)(4,502,000)(5,694,000)(24,428,000)(4,205,000)
Nonoperating income (expense)173,000(78,000)1,000(6,000)(1,000)(3,000)
Gain (loss), foreign currency transaction, before tax33,000(78,000)1,000(5,000)(1,000)(13,000)
Interest and debt expense140,000  (1,000) (1,000)
Loss from continuing operations:(4,026,000)(5,189,000)(4,501,000)(5,701,000)(24,429,000)(4,209,000)
Loss before gain (loss) on sale of properties:(5,701,000)(24,429,000)(4,209,000)
Net loss:(4,026,000)(5,189,000)(4,501,000)(5,701,000)(24,429,000)(4,209,000)
Other undisclosed net income (loss) attributable to parent(140,000)  1,0001,0001,000
Net loss available to common stockholders, diluted:(4,166,000)(5,189,000)(4,501,000)(5,700,000)(24,428,000)(4,208,000)

Comprehensive Income (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(4,026,000)(5,189,000)(4,501,000)(5,701,000)(24,429,000)(4,209,000)
Comprehensive loss, net of tax, attributable to parent:(4,026,000)(5,189,000)(4,501,000)(5,701,000)(24,429,000)(4,209,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: